S. Y. Zhang

发表

E2F-1: a proliferative marker of breast neoplasia.

A. Klein-Szanto, L. Al-Saleem, D. Holloran, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines.

A. Klein-Szanto, D. Johnson, S. Y. Zhang, 2000, Cancer research.

Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.

A. Klein-Szanto, E. Sauter, J. Ridge, 1994, Cancer research.

Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.

A. Klein-Szanto, S. Y. Zhang, B. Ruggeri, 1992, Oncogene.

Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.

A. Klein-Szanto, S. Y. Zhang, B. Ruggeri, 1994, Archives of pathology & laboratory medicine.

Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines.

A. Klein-Szanto, S. Y. Zhang, B. Ruggeri, 1991, The American journal of pathology.

Immunohistochemistry of cyclin D1 in human breast cancer.

A. Klein-Szanto, S. Y. Zhang, X. Guo, 1994, American journal of clinical pathology.

Increased expression of G1 cyclins and cyclin‐dependent kinases during tumor progression of chemically induced mouse skin neoplasms

R. Morris, T. Goodrow, S. Y. Zhang, 1997, Molecular carcinogenesis.

p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

S. Y. Zhang, Andres J Klein-Szanto, J. Caamano, 1993, The American journal of pathology.

Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.

S. Y. Zhang, U. Galili, J. Abrams, 1999, Cancer research.

Preparation of antigastric cancer monoclonal antibody MGb2-mitomycin C conjugate with improved antitumor activity.

S. Y. Zhang, D. Fan, J. Zhang, 1990, Bioconjugate chemistry.

Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.

T. Goodrow, S. Y. Zhang, B. Ruggeri, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.

T. Goodrow, S. Y. Zhang, B. Ruggeri, 1996, Cancer research.

Lack of concordant p53 mutations in some paired primary and metastatic mouse squamous cell carcinomas induced by chemical carcinogenesis

T. Goodrow, S. Y. Zhang, Andres J Klein-Szanto, 1995, Molecular carcinogenesis.

Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.

J. Ridge, J. Babb, S. Y. Zhang, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene.

A. Robles, C. Conti, S. Y. Zhang, 1995, Carcinogenesis.

Studies on antitumor actions of cantharidin.

S. Y. Zhang, J. L. Yang, R. T. Chen, 1980, Chinese medical journal.

Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities.

S. Y. Zhang, B. Ruggeri, Andres J Klein-Szanto, 1994, Carcinogenesis.

Molecular and cytogenetic alterations in human pancreatic cancer: the role of tumor suppressor genes.

S. Y. Zhang, B. Ruggeri, Andres J Klein-Szanto, 1992, Progress in clinical and biological research.